Riptide Therapeutics LLC
Oak Park, IL
- UEI
- C95RHLDBCVB9
- CAGE
- 97YF2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 611 Fair Oaks Ave, Oak Park, IL 60302, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir topic #446 phase i -development of senotherapeutic agents for cancer treatment | National Cancer Institute | $400,000 |
Quick answers
What is Riptide Therapeutics LLC's UEI?
Riptide Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is C95RHLDBCVB9.
What is Riptide Therapeutics LLC's CAGE code?
Riptide Therapeutics LLC's CAGE code is 97YF2.
What is Riptide Therapeutics LLC's primary NAICS code?
Riptide Therapeutics LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Riptide Therapeutics LLC located?
Riptide Therapeutics LLC's physical address in SAM.gov is 611 Fair Oaks Ave, Oak Park, IL 60302, USA.
Is Riptide Therapeutics LLC registered in SAM.gov?
Yes. Riptide Therapeutics LLC's SAM.gov registration is active through July 14, 2027.
What is Riptide Therapeutics LLC's most recent federal award?
Riptide Therapeutics LLC's most recent federal contract award is Sbir topic #446 phase i -development of senotherapeutic agents for cancer treatment (75N91023C00035), from National Cancer Institute, on September 25, 2023.
On GovTribe
See Riptide Therapeutics LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors